Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
Subscribe To Our Newsletter & Stay Updated